Predicting Survival Outcomes in Patients with Hepatocellular Carcinoma Receiving Lenvatinib by Using the Up7-ALBI Score.

Liver Cancer · 2025 · PMC12158439 · PMID 40510573

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Additionally, a Pearson chi-square test indicated that the objective response rate is statistically different among the low-, intermediate-, and high-risk groups, and showed a trend of decreasing objective response rate with higher scores, indicating that the Up7-ALBI score may also serve as an actionable tool for predicting early treatment response.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.